Related Experiment Video
Updated: Jun 23, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Congestive heart failure. Towards a comprehensive treatment
1University Department of Cardiovascular Studies, General Infirmary, Leeds, UK.
European Heart Journal
|April 1, 1996
Summary
Heart failure diagnosis and treatment remain challenging, impacting patient survival despite advances. Echocardiography aids diagnosis, while beta-blockers show promise for comprehensive heart failure management.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Heart failure is a growing health concern with significant healthcare demands.
- Current drug treatments have not substantially improved survival rates in the general population.
- Delayed diagnosis is a key factor hindering timely and effective heart failure treatment.
Purpose of the Study:
- To review current understanding and therapeutic targets in heart failure management.
- To evaluate the role of echocardiography in diagnosis and treatment planning.
- To explore the potential of novel drug classes, such as beta-blockers, in improving heart failure outcomes.
Main Methods:
- Review of existing literature on heart failure pathophysiology and treatment.
- Analysis of the role of echocardiography in diagnosing heart failure.
- Evaluation of pharmacological interventions, including diuretics, vasodilators, ACE-inhibitors, digitalis, and beta-blockers.
Main Results:
- Echocardiography is a reliable and cost-effective tool for diagnosing heart failure.
- Standard treatments (diuretics, vasodilators, ACE-inhibitors) improve symptoms but have limitations.
- Digitalis glycosides offer symptomatic relief but their impact on survival is uncertain.
- Existing therapies do not adequately address neuroendocrine dysregulation, particularly sympathoadrenal overactivity.
Conclusions:
- Optimizing combination therapy for heart failure remains a challenge.
- Beta-adrenoceptor antagonists represent a promising therapeutic strategy for comprehensive heart failure treatment.
- Addressing neuroendocrine factors is crucial for improving heart failure morbidity and mortality.
Related Concept Videos
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...